CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Biogen Neuroscience's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Dec 19, 2018Human Anti-Alpha-Synuclein Antibodies3